Definitive Contract 75F40121C00145

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>

This is a $2,757,330.80 firm-fixed-price Delivery Order awarded by the Food and Drug Administration (FDA) to Palladian Partners, Inc., a for-profit strategic communications and marketing firm. The objective of this task order is to provide comprehensive strategic communication services and support, targeting consumers/patients and building partnerships with patient advocacy organizations. This award is issued under Palladian Partners' Multiple Award Schedule (MAS) contract with the General...

This is a definitive cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Physical Sciences Inc., a for-profit research and development company. The contract was awarded under FDA Broad Agency Announcement BAA-18-00123, titled &quot;Single Vial Mass Flow Rate Sensor Assessment of Freeze Drying Heterogeneity&quot;, with Proposal Number PMQWP#195. The contract has a potential value of $959,248.00 and a completion date of December...

<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>

<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>

This is a definitive contract awarded by the Food and Drug Administration (FDA) to Summer Productions, Inc., a for-profit, woman-owned small business. The contract, titled &quot;FDA Physician Communication Project: Testing with Professional Societies,&quot; has a ceiling value of $313,486.00 and a completion date of September 30, 2016. The contract is a firm fixed-price arrangement and does not have a set-aside designation. The contract supports the FDA's physician communication project, which...

This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in &quot;FORMULA&quot;, and (2) to develop computational models to predict the...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to R &amp; D Enterprises, Inc., a for-profit small business. The contract, worth $95,980.00, is for the delivery of various scientific instruments and accessories used in bio-processing, research, and testing, such as mass spectrometers, thermal conductivity testers, rheometers, colorimeters, thermomechanical analyzers, and titration calorimeters. The contract has an...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...

<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>